Menopause & midlife

GSM Doesn't Fade on Its Own: Why Treatment Matters

Save

Vaginal dryness from menopause rarely resolves on its own. Unlike hot flashes, which often ease within about 7 years, genitourinary syndrome of menopause tends to persist or worsen because estrogen stays low. Low-dose vaginal estrogen and non-hormonal moisturizers can relieve symptoms at any stage [1][3].

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Does vaginal dryness go away without treatment?

Genitourinary syndrome of menopause is a progressive condition, not a phase that passes. According to The North American Menopause Society, GSM affects up to about 50% of postmenopausal women and, unlike some symptoms, does not improve on its own 1. Hot flashes are the contrast most people expect, and they usually do settle over time.

In the SWAN study, vasomotor symptoms lasted a median of roughly 7 years before easing 2. GSM behaves differently because estrogen stays low permanently, so vaginal and urinary tissues keep thinning and symptoms tend to hold steady or slowly worsen. Fewer than 1 in 10 affected women are treated, even though relief is very achievable 1.

Why doesn't GSM improve like hot flashes do?

Estrogen is the reason GSM and hot flashes follow different paths. Hot flashes come from the brain's temperature-control center adjusting to lower estrogen, and over time that system often recalibrates, which is why night sweats and hot flashes frequently settle on their own.

The vulva, vagina, urethra, and bladder are rich in estrogen receptors, so when estrogen falls these tissues become thinner, less elastic, and drier, and the vaginal pH rises. That change is structural and ongoing rather than a passing signal. Left alone it typically accumulates, which is why vaginal dryness after menopause is one of the few menopause symptoms that tends to progress instead of fade 1.

What actually helps GSM?

Effective treatment for GSM restores moisture and tissue health rather than just masking symptoms. For milder cases, regular use of a long-acting vaginal moisturizer plus a lubricant for sex is a reasonable first step. When that is not enough, low-dose vaginal estrogen is the most studied option.

A Cochrane review of local estrogen found it relieved dryness and discomfort more effectively than placebo, with very little estrogen reaching the bloodstream 3. Vaginal DHEA and an oral tissue-selective medication are additional prescription choices a clinician may describe. According to ACOG, low-dose vaginal estrogen carries minimal systemic absorption and can be considered even for many breast cancer survivors after discussion with their oncology team 4. Most people notice meaningful improvement within 2 to 3 months.

Does untreated GSM cause other problems?

Untreated GSM can affect more than comfort. As tissues thin, some women develop recurrent urinary tract infections, new bladder and urinary symptoms, or discomfort that makes sex painful enough to avoid, which can strain intimacy and self-image.

Across life stages the pattern differs. In the perimenopausal transition dryness may be mild and come and go, and temporary low-estrogen states such as breastfeeding can cause dryness that recovers once estrogen returns, but the dryness that begins after the final period usually does not self-correct. Because the change is gradual, many women assume the discomfort is simply aging. It is not inevitable, and untreated symptoms are linked with worse sexual function and quality of life 1.

When a menopause clinician can help

A clinician who treats menopause can confirm that symptoms are from GSM and match you to the right option. Because dryness, itching, or discharge can also come from infection or a skin condition, a brief exam helps rule those out before treatment.

A clinician can also weigh your history, for example whether systemic hormone therapy for other menopause symptoms might address GSM too, or whether a local, low-dose approach fits better. Most women who use vaginal estrogen report their symptoms improve, so this is a highly treatable problem 3. Gale can help you organize your symptoms and questions before that visit.

Common questions

For most women, no. Menopausal dryness comes from a lasting drop in estrogen, so it tends to stay the same or slowly worsen rather than resolve. This differs from hot flashes, which often ease over several years. The encouraging news is that treatment works well whenever it is started.

Low-dose vaginal estrogen delivers hormone directly to the tissue with very little reaching the bloodstream, which is why it is often chosen by women who prefer to avoid systemic hormones. It is even considered for many people with a history of breast cancer after a conversation with their oncology team.

Yes, for milder symptoms. Long-acting vaginal moisturizers used on a regular schedule, plus lubricants during sex, help many women and are a common first step. If they are not enough, prescription options can be added later.

Many women notice improvement within a few weeks, with fuller benefit over two to three months as the tissue rebuilds. Because GSM is ongoing, symptoms usually return if treatment stops, so it is typically continued long term under a clinician's guidance.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When vaginal or urinary symptoms need a clinician's review

  • Vaginal bleeding after menopause is a reason to seek prompt clinician review, since it needs evaluation to rule out other causes.
  • Pain, fever, or foul-smelling discharge along with dryness can signal infection and is a reason to contact a clinician.
  • Burning, urgency, or pain with urination that keeps returning is a reason to seek clinician review for possible recurrent infection.
  • Dryness or irritation that does not improve after a couple of months of treatment is a reason to check back with your clinician.

This article is general health education, not medical advice. Whether and how to treat genitourinary symptoms of menopause depends on your history and exam findings, and should be decided with a gynecologist or menopause clinician.

References

  1. 1.The North American Menopause Society (Menopause Society) (2020). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000001609Genitourinary syndrome of menopause is chronic and progressive, affects up to about half of postmenopausal women, is widely undertreated, and is linked with worse sexual function and quality of life when left untreated.
  2. 2.Avis NE, Crawford SL, Greendale G, et al. / Study of Women's Health Across the Nation (SWAN) (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. doi:10.1001/jamainternmed.2014.8063Vasomotor symptoms such as hot flashes last a median of about 7 years across the menopause transition, used here for the contrast with genitourinary symptoms that do not self-resolve.
  3. 3.Lethaby A, Ayeleke RO, Roberts H (2016). Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001500.pub3Low-dose local (vaginal) estrogen relieves vaginal dryness and atrophy symptoms more effectively than placebo, with little systemic absorption.
  4. 4.American College of Obstetricians and Gynecologists (2016). The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000001351Low-dose vaginal estrogen has minimal systemic absorption and can be considered even for many women with a history of estrogen-dependent breast cancer in consultation with oncology.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy